FDA Adverse Event Other Summary report: N

ACRYSOF

MDR report key: 1941837 · Received December 17, 2010

Report

Report Number
1119421-2010-01436
Event Type
Other
Date Received
December 17, 2010
Date of Event
January 1, 2010
Report Date
November 18, 2010
Manufacturer
ALCON RESEARCH, LTD./HUNTINGTON
Product Code
HQL
PMA / PMN Number
P930014
Removal / Correction Number
NA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE PRODUCT WAS NOT RETURNED FOR ANALYSIS; THE DEVICE REMAINS IMPLANTED. RESULTS FROM THE PRODUCT HISTORY RECORD REVIEW INDICATED THE PRODUCT MET RELEASE CRITERIA. THERE HAVE BEEN NO OTHER COMPLAINTS REPORTED IN THE LOT NUMBER. ADDITIONAL INFO WAS REQUESTED ON 12/14/2010 BY FAX AND MAIL. A COMPLETED QUESTIONNAIRE HAS NOT BEEN RECEIVED. (B)(4).

Description of Event or Problem · 1

A SURGEON REPORTED A PT WITH AN UNEXPECTED OUTCOME FOLLOWING INTRAOCULAR LENS (IOL) IMPLANT SURGERY. THE SURGEON EXPLAINED THAT WHILE DOING THE CCC (CAPSULORRHEXIS) THE CAPSULE SPLIT; AND SWITCHED TO A DIFFERENT MODEL LENS FOR IMPLANTATION IN THE SULCUS. THE IOL WAS LOADED UPSIDE DOWN AND THUS, IMPLANTED REVERSED IN THE SULCUS. ALSO, THE IOL HAPTIC WAS NOTED TO BE CAPTURED IN THE IRIS. DUE TO THESE CIRCUMSTANCES, THE LENS VAULTED FORWARD RESULTING IN A VERY SHALLOW ANTERIOR CHAMBER AND A -3.00D OF MYOPIA (ORIGINAL TARGET REFRACTION WAS PLANO) THAT THE PT HAS DECIDED THAT HE IS VERY HAPPY WITH DUE TO J1+ NEAR VISION. THE SURGEON DOES NOT THINK THE IOL IS DEFECTIVE AND THAT THE REASON FOR THE EVENT WAS THAT THE LENS WAS LOADED UPSIDE DOWN IN THE CARTRIDGE. ADDITIONALLY, THE SURGEON REPORTED THAT, DUE TO THE FACT THAT THE CATARACT WAS SO DENSE, SHE IS NOT CONFIDENT THE CONTACT A-SCAN IS COMPLETELY ACCURATE. ADDITIONAL INFO HAS BEEN REQUESTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACRYSOF INTRAOCULAR LENS HQL ALCON RESEARCH, LTD./HUNTINGTON MN60AC 10852262

Patients

Seq Age Sex Outcome Treatment
1 Other